COGNITIVE EFFECTS OF SHORT-TERM USE OF RALOXIFENE: A RANDOMIZED CLINICAL TRIAL

REFERENCES

• Anderson G. L., Limacher M., Assaf A. R., Bassford T, Beresford Sx˙ Ax˙ A, Black H, Bonds D., Brunner R, Brzyski R, Caan B, Chlebowski R, Curb D, Gass M, Hays J, Heiss G, Hendrix S, Howard Bx˙ V, Hsia J, Hubbell A, Jackson R, Johnson Kx˙ C, Judd H, Kotchen Jx˙ M, Kuller L, LaCroix Ax˙ Z, Lane D, Langer Rx˙ D, Lasser N, Lewis Cx˙ E, Manson J, Margolis K, Ockene J, O'Sullivan Mx˙ J, Phillips L, Prentice Rx˙ L, Ritenbaugh C, Robbins J, Rossouw Jx˙ E, Sarto G, Stefanick Mx˙ L, Van Horn L, Wactawski-Wende J, Wallace R, Wassertheil-Smoller S. Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: The Women's Health Initiative randomized controlled trial. Journal of the American Medical Association 2004; 291: 1701–1712
   PubMed Web of Science ®Google Scholar
• Bryant H. U., Bales K. R., Paul S. M. Estrogen agonist effects of selective estrogen receptor modulators in ovariectomized rat brain (Abstract). Society for Neurosciences Abstracts 1997; 23: 2377
   Google Scholar
• Clemens J. A., Bennett D. R., Black L. J., Jones Cx˙ D. Effects of a new antiestrogen, keoxifene, on growth of carcinogen-induced mammary tumors and on LH and prolactin levels. Life Sciences 1983; 32(25)2869–2875
   PubMed Web of Science ®Google Scholar
• Diaz Brinton R., Chen S., Montoya M., Hsieh D, Minaya J, Kim J, Chu Hx˙-P. The women's health initiative estrogen replacement therapy is neurotrophic and neuroprotective. Neurobiology of Aging 2000; 21(3)475–496
   PubMedGoogle Scholar
• Drake E., Henderson V., Stanczyk F., McCleary Cx˙ A, Brown Wx˙ S, Smith Cx˙ A, Rizzo Ax˙ A, Murdock Gx˙A, Buckwalter Jx˙ G. Associations between circulating sex steroid hormones and cognition in normal elderly women. Neurology 2000; 54(3)599–603
   PubMed Web of Science ®Google Scholar
• Francucci C. M., Romagni P., Boscaro M. Raloxifene: Bone and cardiovascular effects. Journal of Endocrinology Investigation 2005; 28(10 Supplement)85–89
   PubMedGoogle Scholar
• Gibbs R. B. Oestrogen and the cholinergic hypothesis: Implications for oestrogen replacement therapy in postmenopausal women. Novartis Foundation Symposium 2000; 230: 94–111
   PubMedGoogle Scholar
• Grady D., Herrington D., Bittner V., Blumenthal R, Davidson M, Hlatky M, Hsia J, Hulley S, Herd A, Khan S, Newby Lx˙ K, Waters D, Vittinghoff E, Wenger N. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin replacement study follow-up (HERS II). Journal of the American Medical Association 2002; 288(1)49–57
   PubMed Web of Science ®Google Scholar
• Henderson V. W., Watt L., Buckwalter J. G. Cognitive skills associated with estrogen replacement in women with Alzheimer's disease. Psychoneuroendocrinology 1996; 21(4)421–430
   PubMedGoogle Scholar
• Hulley S., Furberg C., Barrett-Connor E., Cauley J, Grady D, Haskell W, Knopp R, Lowery M, Satterfield S, Schrott H, Vittinghoff E, Hunninghake D. Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin replacement study follow-up (HERS II). Journal of the American Medical Association 2002; 288(1)58–66
   Google Scholar
• Hulley S., Grady D., Bush T., Furberg C, Herrington D, Riggs B, Vittinghoff E. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. Journal of the American Medical Association 1998; 280(7)605–613
   PubMed Web of Science ®Google Scholar
• Kampen Dx˙ L, Sherwin Bx˙ B. Estrogen use and verbal memory in healthy postmenopausal women. Obstetrics and Gynecology 1994; 83(6)979–983
   PubMed Web of Science ®Google Scholar
• Leranth C., Roth R. H., Elswoth Jx˙Dx˙ F, Horvath Tx˙ L, Redmond Dx˙ Ex˙ Jr. Estrogen is essential for maintaining nigrostriatal dopamine neurons in primates: Implications for Parkinson's disease and memory. Journal of Neuroscience 2000; 20(23)8604–8609
   PubMedGoogle Scholar
• Nickelsen T, Lufkin Ex˙ G, Riggs Bx˙ L, Cox Dx˙ A, Crook Tx˙ H. Raloxifene hydrochloride, a selective estrogen receptor modulator: Safety assessment of effects on cognitive function and mood in postmenopausal women. Psychoneuroendocrinology 1999; 24(1)115–128
   PubMed Web of Science ®Google Scholar
• Osterlund M. K., Halldin C., Hurd Y. L. Effects of chronic 17beta-estradiol treatment on the serotonin 5-HT(1A) receptor mRNA and binding levels in the rat brain. Synapse 2000; 35(1)39–44
   PubMedGoogle Scholar
• Phillips S. M., Sherwin B. B. Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology 1992; 17(5)485–495
   PubMed Web of Science ®Google Scholar
• Rapp S., Espeland M. A., Shumaker S. A., Henderson Vx˙ W, Brunner Rx˙ L, Manson Jx˙ E, Gass Mx˙ Lx˙ S, Stefanick Mx˙ L, Lane Dx˙ S, Hays J, Johnson Kx˙ C, Coker Lx˙ H., Dailey M, Bowen D. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: Women's Health Initiative Memory Study; A Randomized Controlled Trial. Journal of the American Medical Association 2003; 289: 2663–2672
   PubMed Web of Science ®Google Scholar
• Robinson D, Friedman L, Marcus R, Tinklenberg J., Yesavage J. Estrogen replacement therapy and memory in older women. Journal of the American Geriatrics Society 1994; 42(9)919–922
   PubMedGoogle Scholar
• Rossouw J. E., Anderson G. L., Prentice R. L., LaCroix Ax˙ Z, Kooperberg C, Stehanick Mx˙ L, Jackson Rx˙ D, Beresford Sx˙ A, Howard Bx˙ V, Johnson Kx˙ C, Kotchen Jx˙ M, Ockene J. Writing Group for the Women's Health Initiative Investigators Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. Journal of the American Medical Association 2002; 288(3)321–333
   PubMed Web of Science ®Google Scholar
• Sherwin B. B. Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women. Psychoneuroendocrinology 1988; 13(4)345–357
   PubMed Web of Science ®Google Scholar
• Shughrue P. J., Lane M. V., Merchenthaler I. Regulation of progesterone receptor messenger ribonucleic acid in the rat medial preoptic nucleus by estrogenic and antiestrogenic compounds: An in situ hybridization study. Endocrinology 1997; 138(12)5476–5484
   PubMedGoogle Scholar
• Shumaker S. A., Legault C., Kuller L., Rapp Sx˙ R, Thaell L, Lane Dx˙ S, Fillit H, Stefanick Mx˙ L, Hendrix Sx˙ L, Lewis Cx˙ E, Masaki K, Coker Lx˙ H. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. Journal of the American Medical Association 2004; 291(24)2947–2958
   PubMed Web of Science ®Google Scholar
• Shumaker S. A., Legault C., Rapp S. R. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women. The Women's Health Initiative Memory Study: A randomized controlled trial. Journal of the American Medical Association 2003; 289: 2651–2662
   PubMed Web of Science ®Google Scholar
• Wassertheil-Smoller S, Hendrix S.L, Limacher M, Heiss G, Kooperberg C, Baird A, Kotchen T, Curb Jx˙ D, Black H, Rossouw Lx˙ E, Aragaki A, Safford M, Stein E, Laowattana S, Mysiw Wx˙ J. Effect of estrogen plus progestin on stroke in postmenopausal women: The Women's Health Initiative: A randomized trial. Journal of the American Medical Association 2003; 28(20)2673–2684
   Google Scholar
• Yaffe K, Krueger K, Sarkar S, Grady D, Barrett-Connor E, Cox Dx˙ A, Nickelsen T. Cognitive function in postmenopausal women treated with raloxifene. New England Journal of Medicine 2001; 344(16)1207–1213
   PubMedGoogle Scholar